MedTrace Logo

Impact of the COVID-19 Pandemic on the Health Status of People Aged 75 and Over and Their Caregivers

NCT05249868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1035

Last updated 2025-09-03

No results posted yet for this study

Summary

The measures to control the transmissibility of the Covid-19 pandemic have changed the daily routines of the population, increasing sedentary lifestyles, decreasing outdoor physical activity and limiting contact with neighbors, family and friends. This could be having negative consequences for the health of vulnerable people.

The investigators want to know how this situation has affected the health of people aged 75 years or older and their caregivers and how the circumstances experienced may mark new care needs.

To this end, will be analyzed clinical data, follow up people who have become ill with COVID-19 and those who have not, and interview groups of caregivers and patients to hear about the personal impact of the pandemic on them.

This will allow us to explore what changes are needed in health care to achieve an improvement in the health and quality of life of this population.

CUIDAMOS+75 seeks the commitment of the population and of the different people in charge of the health services from the very beginning.

Conditions

Interventions

OTHER

Exposure SARS-CoV-2 Infection

The exposure variable is confirmed SARS-CoV-2 infection with diagnosis after 11 May 2020. Positive confirmatory test on nucleic acid amplification (rRT-PCR) or having had symptoms for \<5 days is positive on a PRAg test.

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Hospital del Mar Research Institute (IMIM)

    collaborator OTHER

  • Fundación para la Investigación e Innovación Biosanitaria de la Comunidad de Madrid

    collaborator UNKNOWN

  • Gerencia de Atención Primaria, Madrid

    lead OTHER_GOV

Principal Investigators

  • Milagros Rico-Blázquez, Master · Gerencia Asistencial de Atención Primaria de Madrid

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-12-01
Completion
2025-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05249868 on ClinicalTrials.gov